Hiroshima University researchers have demonstrated a proof of concept for the mass production of genome-edited T cells that can be used to treat malignant tumors, using a genetic engineering technique called Platinum TALEN.
Jul 6, 2026
0
7
Breast cancers diagnosed during the first three years after childbirth, particularly within the first year, may be biologically more aggressive than similar cancers in women who have never given birth, according to a new ...
Jul 8, 2026
0
7
Obesity rates among U.S. adults and children rose sharply in recent years, and by 2023, 40% of adults and 20% of youth met the criteria for obesity, according to new, independent research published in Circulation.
Jul 8, 2026
0
7
If you're a woman newly diagnosed with breast cancer, treatment can feel ... well, scary. Will chemotherapy work? Or will it become a cycle of educated guesswork: trying one drug combination, waiting, scanning? If the tumor ...
Jul 7, 2026
0
7
Childhood vaccination rates have slumped globally. In several countries, people are more hesitant about getting vaccinated. Populist political actors promote distrust of government and scientific institutions. And the disinformation ...
Jul 3, 2026
0
7
Researchers at the University of Liverpool have identified distinctive biological characteristics within adenomyosis lesions that could help pave the way for more targeted, less invasive treatments. The findings from a team ...
Jul 3, 2026
0
7
A parasite that causes severe, watery diarrhea is spreading across the United States, and health officials in Michigan are racing to explain an unusual surge in cases.
Jul 7, 2026
0
7
A new platform developed by researchers at the University of Texas MD Anderson Cancer Center quickly finds and isolates rare, tumor-reactive immune cells that are especially good at recognizing and attacking cancer cells, ...
Jul 8, 2026
0
7
The company can now market flavored pouches as less harmful than cigarettes, alarming health experts.
Jul 8, 2026
0
7
Glioblastoma, the most aggressive malignant brain tumor in adults, remains one of the most challenging cancers to treat because of limited treatment options and a poor prognosis. Patient outcomes have remained largely unchanged ...
12 hours ago
0
7
